These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 20811709

  • 1. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K, Nakagawa K, Hamada J, Hida Y, Tada M, Kondo S, Moriuchi T.
    Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
    [Abstract] [Full Text] [Related]

  • 2. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
    [Abstract] [Full Text] [Related]

  • 3. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T, Riccardi A, Sanguinetti M, Dominici C, Riccardi R.
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, Jiang T, Rainov NG, Li B, Ren H.
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
    Li L, Blumenthal DK, Masaki T, Terry CM, Cheung AK.
    J Cell Biochem; 2006 Dec 15; 99(6):1553-63. PubMed ID: 16817200
    [Abstract] [Full Text] [Related]

  • 6. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
    Pietras K, Pahler J, Bergers G, Hanahan D.
    PLoS Med; 2008 Jan 29; 5(1):e19. PubMed ID: 18232728
    [Abstract] [Full Text] [Related]

  • 7. Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.
    Terabe F, Kitano M, Kawai M, Kuwahara Y, Hirano T, Arimitsu J, Hagihara K, Shima Y, Narazaki M, Tanaka T, Kawase I, Sano H, Ogata A.
    Mod Rheumatol; 2009 Jan 29; 19(5):522-9. PubMed ID: 19568828
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
    Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R.
    Cancer; 2008 May 15; 112(10):2119-29. PubMed ID: 18338812
    [Abstract] [Full Text] [Related]

  • 9. Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner.
    Molgat AS, Gagnon A, Sorisky A.
    Am J Physiol Cell Physiol; 2009 Apr 15; 296(4):C757-65. PubMed ID: 19225164
    [Abstract] [Full Text] [Related]

  • 10. Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases.
    Mueller L, Goumas FA, Himpel S, Brilloff S, Rogiers X, Broering DC.
    Cancer Lett; 2007 Jun 08; 250(2):329-38. PubMed ID: 17141949
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin.
    Fan KJ, Yang B, Liu Y, Tian XD, Wang B.
    Mol Med Rep; 2017 Dec 08; 16(6):9758-9762. PubMed ID: 29039563
    [Abstract] [Full Text] [Related]

  • 12. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
    Abouantoun TJ, MacDonald TJ.
    Mol Cancer Ther; 2009 May 08; 8(5):1137-47. PubMed ID: 19417143
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 14. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, Yeh MM, Alpers CE, Fausto N.
    Differentiation; 2007 Nov 15; 75(9):843-52. PubMed ID: 17999742
    [Abstract] [Full Text] [Related]

  • 15. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M.
    Hepatology; 2013 Sep 15; 58(3):1042-53. PubMed ID: 23505219
    [Abstract] [Full Text] [Related]

  • 16. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
    Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ.
    J Natl Cancer Inst; 2003 Mar 19; 95(6):458-70. PubMed ID: 12644539
    [Abstract] [Full Text] [Related]

  • 17. PDGF BB induces VEGF secretion in ovarian cancer.
    Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW.
    Cancer Biol Ther; 2007 Dec 19; 6(12):1951-9. PubMed ID: 18075302
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L, Paridaens D, Dingjan GM, van Daele PL, van Hagen PM, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2010 Feb 19; 51(2):1002-7. PubMed ID: 19797221
    [Abstract] [Full Text] [Related]

  • 19. The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
    Virakul S, Dalm VA, Paridaens D, van den Bosch WA, Hirankarn N, van Hagen PM, Dik WA.
    Graefes Arch Clin Exp Ophthalmol; 2014 Jul 19; 252(7):1101-9. PubMed ID: 24874745
    [Abstract] [Full Text] [Related]

  • 20. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y, Gagnon A, Sorisky A.
    J Cell Physiol; 2009 Jan 19; 218(1):228-36. PubMed ID: 18814181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.